Puregon
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background Infertility, or impaired fecundity, affects 11.8% of women between the ages of 15 and 44, which translates to 7.3…
Objective To assess the efficacy and safety in clinical practice of a low dose regimen of 50 IU of recombinant follicle…
Although many assisted conception technologies exist—and have a bewildering array of acronyms—their principal aim is similar…
BACKGROUND
This is the first report of human exposure to the novel compound follicle stimulating hormone (FSH)-C-terminal peptide…
We investigated whether a recombinant follicle stimulating hormone (FSH) (Puregon) can be administered less frequently and at…
There is still a paucity of published real-life clinical experience with the use of first generation recombinant follicle…
Glycoforms of recombinant human follicle stimulating hormone (rhFSH) (Org 32489, Puregon) were characterized using concanavalin A…
Inhibin (and its alpha-subunit) may be of particular value as a marker for follicular development in in-vitro fertilization (IVF…
The objective of this study was to compare the efficacy and safety of a recombinant follicle stimulating hormone (FSH…